SpringWorks Therapeutics, Inc. (SWTX)
Jul 1, 2025 - SWTX was delisted (reason: acquired by Merck KGaA)
46.99
0.00 (0.00%)
Inactive · Last trade price on Jun 30, 2025
SpringWorks Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$56.86
Upside
+21.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Hold Reiterates $47 | Hold | Reiterates | $47 | +0.02% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $74 → $47 | Strong Buy → Hold | Downgrades | $74 → $47 | +0.02% | Apr 30, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades $77 → $47 | Strong Buy → Hold | Downgrades | $77 → $47 | +0.02% | Apr 29, 2025 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $66 → $47 | Strong Buy → Hold | Downgrades | $66 → $47 | +0.02% | Apr 29, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades $63 → $47 | Buy → Hold | Downgrades | $63 → $47 | +0.02% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +57.48% | Feb 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +57.48% | Feb 21, 2025 |
| Wedbush | Wedbush | Buy Reiterates $77 | Buy | Reiterates | $77 | +63.86% | Feb 12, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +38.33% | Feb 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +57.48% | Feb 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $80 → $78 | Strong Buy | Maintains | $80 → $78 | +65.99% | Jan 8, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $60 | Buy | Initiates | $60 | +27.69% | Nov 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $76 → $74 | Strong Buy | Maintains | $76 → $74 | +57.48% | Nov 12, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $64 → $68 | Buy | Maintains | $64 → $68 | +44.71% | Sep 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $76 | Strong Buy | Reiterates | $76 | +61.74% | Aug 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +57.48% | Jun 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.